Final answer:
Reglan (metoclopramide), used to induce lactation, can lead to an increased risk of excess prolactin production, causing side effects such as amenorrhea, galactorrhea, and breast enlargement.
Step-by-step explanation:
Reglan (metoclopramide) is often used to induce lactation by increasing prolactin levels, which is essential for milk production. However, this drug can lead to an increased risk of excess prolactin production. Excess prolactin can result in several side effects, such as amenorrhea (absence of menstruation), galactorrhea (unnecessary discharge of milk), and enlargement of the breasts. It's important for individuals considering medication for lactation induction, such as those following the Zil Goldstein or Newman-Goldfarb protocols, to be aware of the potential risks associated with drugs that are not approved by the Food and Drug Administration, like domperidone. Physical stimulation of the nipples is also recommended for milk production as part of these protocols.